Regeneron to Host Conference Call on January 3 at 8:30am EST to Discuss Ongoing Patent Litigation

Loading...
Loading...
Regeneron Pharmaceuticals
REGN
announced that it will host a conference call on Tuesday, January 3, 2012 at 8:30 a.m. Eastern Time to provide an update on the status of the ongoing patent litigation with Genentech, a member of the Roche Group (
RHHBY
).
Market News and Data brought to you by Benzinga APIs
Posted In: NewsLegalPre-Market Outlook
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...